HopeStage
Back to all studies
CompletedNCT00712699

Extended-release amphetamine or placebo for preschool ADHD

About this titleRead the official source — NCT00712699
Medication studyAges 36–66 months
The study in practice

Understand this study

Who was this study for?

Listed age limits: 36 months to 66 months.

Participation duration
6 weeks

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJune 2008
Recruitment status
Completed
Enrollment listed in the registry
27
Sponsor
Baystate Medical Center
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Locations
Not clearly listed
Age range
From 36 Months to 66 Months
Official registry ID
NCT00712699
Official title
Show the full official title

Placebo vs. Extended Release Stimulant Crossover Trial in Preschoolers With ADHD

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Locations not listed

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Baystate Medical Center, a hospital or academic medical center.

Did this study involve medication?

Yes. The study involved medication, including Sequence 1: XR-MAS then placebo and Sequence 2 Placebo then XR-MAS.

Who was this study for?

Listed age limits: 36 months to 66 months.

Want to explore more studies?

Explore studies